We are live on
!
Find out more
MAA
Managed Account Advisors Portfolio holdings
AUM
$121B
1-Year Est. Return
7.32%
This Fund
S&P 500
This Quarter
Est. Return
+5.07%
1 Year Est. Return
+7.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101B
AUM Growth
+$11.3B
(+13%)
Cap. Flow
+$7.67B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
2,867
New
173
Increased
1,129
Reduced
1,339
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$467M |
| 2 |
Kinder Morgan
KMI
|
+$364M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$330M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$291M |
| 5 |
iShares MBS ETF
MBB
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$305M |
| 2 |
Gilead Sciences
GILD
|
+$142M |
| 3 |
Halliburton
HAL
|
+$107M |
| 4 |
GSK
GSK
|
+$81.3M |
| 5 |
Microsoft
MSFT
|
+$81.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.47% |
| 2 | Healthcare | 12.04% |
| 3 | Technology | 11.57% |
| 4 | Industrials | 9.75% |
| 5 | Consumer Discretionary | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
CONMED
CNMD
$1.31B
| $81K | ﹤0.01% |
1,792
+736
| +70% | +$30.8K |
|
|
IFLN
2327
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$308M
| $81K | ﹤0.01% |
4,309
+1,912
| +80% | +$36.3K |
|
|
AERI
2328
DELISTED
Aerie Pharmaceuticals
AERI
| $81K | ﹤0.01% |
+2,769
| New | +$70.2K |
|
2329
FormFactor
FORM
$7.7B
| $79K | ﹤0.01% |
9,095
+1,097
| +14% | +$8.62K |
|
2330
TC Energy
TRP
$71.2B
| $79K | ﹤0.01% |
1,615
+1,538
| +1,997% | +$74.6K |
|
|
HZNP
2331
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $79K | ﹤0.01% |
6,126
-11,579
| -65% | -$145K |
|
2332
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.49B
| $78K | ﹤0.01% |
+1,280
| New | +$79.7K |
|
|
SONC
2333
DELISTED
Sonic Corp
SONC
| $77K | ﹤0.01% |
2,833
+402
| +17% | +$10.2K |
|
2334
Ultragenyx Pharmaceutical
RARE
$2.65B
| $76K | ﹤0.01% |
+1,726
| New | +$79.1K |
|
|
STL
2335
DELISTED
Sterling Bancorp
STL
| $76K | ﹤0.01% |
5,255
+2,243
| +74% | +$30.4K |
|
|
HK
2336
DELISTED
Halcon Resources Corporation
HK
| $76K | ﹤0.01% |
247
-94
| -28% | -$43.5K |
|
2337
QuidelOrtho
QDEL
$1.15B
| $75K | ﹤0.01% |
2,591
+1,094
| +73% | +$29.6K |
|
|
HDP
2338
DELISTED
Hortonworks, Inc.
HDP
| $75K | ﹤0.01% |
+2,766
| New | +$70.2K |
|
|
CPLA
2339
DELISTED
Capella Education Company
CPLA
| $75K | ﹤0.01% |
981
-159
| -14% | -$10.9K |
|
2340
Columbus McKinnon
CMCO
$472M
| $73K | ﹤0.01% |
2,612
+1,098
| +73% | +$28.6K |
|
2341
Nexstar Media Group
NXST
$5.67B
| $73K | ﹤0.01% |
1,411
-4,551
| -76% | -$210K |
|
|
EOPN
2342
DELISTED
E2OPEN INC COM STK (DE)
EOPN
| $70K | ﹤0.01% |
7,296
+533
| +8% | +$3.82K |
|
|
SAAS
2343
DELISTED
inContact, Inc.
SAAS
| $69K | ﹤0.01% |
7,871
+4,256
| +118% | +$35.7K |
|
2344
NETGEAR
NTGR
$681M
| $67K | ﹤0.01% |
1,885
+800
| +74% | +$27.1K |
|
|
CRAY
2345
DELISTED
Cray, Inc.
CRAY
| $67K | ﹤0.01% |
1,956
-406
| -17% | -$12.9K |
|
|
BNCL
2346
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $67K | ﹤0.01% |
5,965
-322
| -5% | -$3.8K |
|
2347
Kadant
KAI
$3.69B
| $66K | ﹤0.01% |
1,546
+662
| +75% | +$26.8K |
|
|
MODV
2348
DELISTED
ModivCare
MODV
| $65K | ﹤0.01% |
1,772
-246
| -12% | -$9.64K |
|
|
COBZ
2349
DELISTED
CoBiz Financial,Inc
COBZ
| $65K | ﹤0.01% |
4,988
-975
| -16% | -$11.7K |
|
2350
City Holding Co
CHCO
$2.03B
| $63K | ﹤0.01% |
1,353
+571
| +73% | +$25.3K |
|
Similar funds
FSIM
HC
SCVF
CG
STI
HC
GMCM
RRC
Managed Account Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Managed Account Advisors held 2,867 positions worth $101B, up 13% from $89.7B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Managed Account Advisors deployed $7.67B of net new capital in Q4 2014, opening 173 new positions and adding to 1,129 existing holdings. Its largest new stake was Schwab US Dividend Equity ETF: 9,780,387 shares worth $130M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $142M trimmed.
- Managed Account Advisors's largest Q4 2014 buy was Schwab US Dividend Equity ETF: 9,780,387 shares worth $130M.
- Managed Account Advisors added most to iShares Russell 1000 Growth ETF in Q4 2014, an estimated $467M increase.
- Managed Account Advisors's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $142M.
- Managed Account Advisors fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $305M.
- Managed Account Advisors's ten largest holdings make up 9.1% of its $101B portfolio in Q4 2014.
- Managed Account Advisors opened 173 new positions and closed 119 in Q4 2014.
- Managed Account Advisors's portfolio value rose 13% quarter-over-quarter to $101B.
Based on Managed Account Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.